EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent???Update 2013, European Urology, vol.65, issue.1, pp.124-161, 2014. ,
DOI : 10.1016/j.eururo.2013.09.046
EAU Guidelines on Prostate Cancer, European Urology, vol.48, issue.4, pp.546-51, 2005. ,
DOI : 10.1016/j.eururo.2005.06.001
EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer, European Urology, vol.65, issue.2, pp.467-79, 2014. ,
DOI : 10.1016/j.eururo.2013.11.002
Optimization of Prostate Biopsy, Urologic Clinics of North America, vol.41, issue.2, pp.648-58, 2014. ,
DOI : 10.1016/j.ucl.2014.01.011
The Expanding Role of MRI in Prostate Cancer, American Journal of Roentgenology, vol.201, issue.6, 2013. ,
DOI : 10.2214/AJR.12.10178
Prostate Cancer: Role of Pretreatment Multiparametric 3-T MRI in Predicting Biochemical Recurrence After Radical Prostatectomy, American Journal of Roentgenology, vol.202, issue.5, pp.459-65, 2014. ,
DOI : 10.2214/AJR.13.11381
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis, Clinical Radiology, vol.63, issue.4, pp.387-95, 2008. ,
DOI : 10.1016/j.crad.2007.05.022
Recommandations en onco-urologie 2013 du CCAFU: cancer de la prostate, Prog Urol, vol.2313, pp.67-101, 2013. ,
Laparoscopic Sentinel Lymph Node Versus Hyperextensive Pelvic Dissection for Staging Clinically Localized Prostate Carcinoma: A Prospective Study of 200 Patients, Journal of Nuclear Medicine, vol.55, issue.5, pp.753-761, 2014. ,
DOI : 10.2967/jnumed.113.129023
URL : http://jnm.snmjournals.org/content/55/5/753.full.pdf
Prostate Cancer: PET with 18F-FDG, 18F- or 11C-Acetate, and 18F- or 11C-Choline, Journal of Nuclear Medicine, vol.52, issue.1, pp.81-90, 2011. ,
DOI : 10.2967/jnumed.110.077941
URL : http://jnm.snmjournals.org/content/52/1/81.full.pdf
Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers, J Nucl Med, vol.42, pp.1805-1819, 2001. ,
Choline PET or PET/CT and Biochemical Relapse of Prostate Cancer, Clinical Nuclear Medicine, vol.38, issue.5, pp.305-319, 2013. ,
DOI : 10.1097/RLU.0b013e3182867f3c
F Choline PET/CT in the Preoperative Staging of Prostate Cancer in Patients with Intermediate or High Risk of Extracapsular Disease: A Prospective Study of 130 Patients, Radiology, vol.254, issue.3, pp.925-958, 2010. ,
DOI : 10.1148/radiol.09090413
Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates, Urologic Oncology: Seminars and Original Investigations, vol.31, issue.4, pp.427-462, 2013. ,
DOI : 10.1016/j.urolonc.2010.08.008
The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer, European Urology, vol.59, issue.1, pp.51-60, 2011. ,
DOI : 10.1016/j.eururo.2010.09.004
Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET, J Nucl Med, vol.47, pp.262-271, 2006. ,
Comparison of different methods for delineation of 18F-FDG PETpositive tissue for target volume definition in radiotherapy of patients with nonsmall cell lung cancer, J Nucl Med, vol.46, pp.1342-1350, 2005. ,
A partial volume effect correction tailored for 18F-FDG-PET oncological studies, Biomed Res Int, p.780458, 2013. ,
DOI : 10.1155/2013/780458
URL : http://doi.org/10.1155/2013/780458
Dual-Phase PET-CT to Differentiate [18F]Fluoromethylcholine Uptake in Reactive and Malignant Lymph Nodes in Patients with Prostate Cancer, PLoS ONE, vol.154, issue.2, 2012. ,
DOI : 10.1371/journal.pone.0048430.t003
URL : https://doi.org/10.1371/journal.pone.0048430
PET Imaging of Prostate Cancer Using Radiolabeled Choline, PET Clinics, vol.4, issue.2, pp.173-84, 2009. ,
DOI : 10.1016/j.cpet.2009.06.003
Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence, Nuklearmedizin, vol.48, issue.1, pp.1-9, 2009. ,
DOI : 10.3413/nukmed-0194
Dual-phase 11C-choline PET/computed tomography in the early evaluation of prostate cancer recurrence, Nuclear Medicine Communications, vol.36, issue.1, pp.8-15, 2015. ,
DOI : 10.1097/MNM.0000000000000207
The age of reason for FDG PET image-derived indices, European Journal of Nuclear Medicine and Molecular Imaging, vol.25, issue.3, pp.1670-1672, 2012. ,
DOI : 10.1038/nbt1306
URL : https://hal.archives-ouvertes.fr/inserm-00733622
Repeatability of 18F-FDG Uptake Measurements in Tumors: A Metaanalysis, Journal of Nuclear Medicine, vol.53, issue.5, pp.701-709, 2012. ,
DOI : 10.2967/jnumed.111.095299
, Conflict of Interest Statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms ,